{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:02:45Z","timestamp":1790373765746,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.ijpharm.2008.05.033","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T08:36:05Z","timestamp":1212654965000},"page":"141-149","source":"Crossref","is-referenced-by-count":12,"title":["Polymorphic control of inhalation microparticles prepared by crystallization"],"prefix":"10.1016","volume":"361","author":[{"given":"Darragh","family":"Murnane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2008.05.033_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1063\/1.1750380","article-title":"Kinetics of phase change I\u2014general theory","volume":"7","author":"Avrami","year":"1939","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1063\/1.1750631","article-title":"Kinetics of phase change. II. Transformation-time relations for random distribution of nuclei","volume":"8","author":"Avrami","year":"1940","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1063\/1.1750872","article-title":"Granulation, phase change, and microstructure\u2014kinetics of phase change III","volume":"9","author":"Avrami","year":"1941","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1021\/op990160z","article-title":"Control of the physical form of salmeterol xinofoate","volume":"3","author":"Beach","year":"1999","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib5","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1002\/(SICI)1521-3773(19991203)38:23<3440::AID-ANIE3440>3.0.CO;2-#","article-title":"Concomitant polymorphs","volume":"38","author":"Bernstein","year":"1999","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/cg030025k","article-title":"Polymorph selection: challenges for the future?","volume":"3","author":"Blagden","year":"2003","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/jps.10115","article-title":"Effects of mechanical processing on phase composition","volume":"91","author":"Brittain","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF01197379","article-title":"Polymorphism of pharmaceuticals and other molecular-crystals. 1. Theory of thermodynamic rules","volume":"2","author":"Burger","year":"1979","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.ijpharm.2008.05.033_bib9","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/jps.20328","article-title":"Studies on the crystallinity of a pharmaceutical development drug substance","volume":"94","author":"Byard","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejps.2005.08.013","article-title":"The effect of crystal morphology and mill type on milling induced crystal disorder","volume":"27","author":"Chikhalia","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib11","first-page":"339","article-title":"Pharmacological agents used to treat asthma","author":"Chung","year":"2003","journal-title":"Eur. Respir. Monogr."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1107\/S0108768194012036","article-title":"Phase changes and chemical reactions in molecular crystals","volume":"51","author":"Dunitz","year":"1995","journal-title":"Acta Crystallogr. B"},{"key":"10.1016\/j.ijpharm.2008.05.033_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-5173(94)00132-4","article-title":"Increased metastable solubility of milled griseofulvin, depending on the formation of a disordered surface structure","volume":"111","author":"Elamin","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1107\/S0108767395013651","article-title":"Direct methods and powder data: state of the art and perspectives","volume":"52","author":"Giacovazzo","year":"1996","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.ijpharm.2008.05.033_bib15","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1007\/s11095-006-9042-1","article-title":"The effects of milling on the surface properties of form I paracetamol crystals","volume":"23","author":"Heng","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib16","series-title":"Nucleation: Basic Theory with Applications","author":"Kaschiev","year":"2000"},{"key":"10.1016\/j.ijpharm.2008.05.033_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1088\/0034-4885\/59\/2\/002","article-title":"Powder diffraction","volume":"59","author":"Langford","year":"1996","journal-title":"Rep. Progress Phys."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0378-5173(01)00880-8","article-title":"The impact of low levels of amorphous material (<5%) on the blending characteristics of a direct compression formulation","volume":"231","author":"Mackin","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-5173(01)00881-X","article-title":"Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry","volume":"231","author":"Mackin","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0040-6031(96)03039-0","article-title":"On the determination of nucleation and growth kinetics by calorimetry","volume":"288","author":"Michaelsen","year":"1996","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ijpharm.2008.05.033_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0169-409X(01)00100-4","article-title":"Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes","volume":"48","author":"Morris","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2007.09.016","article-title":"Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization","volume":"69","author":"Murnane","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpb.2007.10.014","article-title":"Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization","volume":"69","author":"Murnane","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/jps.10394","article-title":"Inverse gas chromatography: considerations about appropriate use for amorphous and crystalline powders","volume":"92","author":"Planinsek","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib25","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/08942680150506303","article-title":"The influence of lung deposition on clinical response","volume":"14","author":"Pritchard","year":"2001","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2004.02.001","article-title":"Optimisation of powders for pulmonary delivery using supercritical fluid technology","volume":"22","author":"Rehman","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/js980490h","article-title":"Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems","volume":"88","author":"Rodriguez-Hornedo","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib28","doi-asserted-by":"crossref","first-page":"B77","DOI":"10.1088\/0022-3727\/26\/8B\/011","article-title":"Polymorphic transformations in crystal-growth","volume":"26","author":"Sato","year":"1993","journal-title":"J. Phys. D: Appl. Phys."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib29","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jps.20644","article-title":"Analytical techniques for quantification of amorphous\/crystalline phases in pharmaceutical solids","volume":"95","author":"Shah","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib30","first-page":"178","article-title":"Physical properties of supercritically-processed and micronised powders for respiratory drug delivery","author":"Shekunov","year":"2002","journal-title":"\u201cKONA\u201d Powder Sci. Technol. Jpn."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0022-0248(99)00819-2","article-title":"Crystallization processes in pharmaceutical technology and drug delivery design","volume":"211","author":"Shekunov","year":"2000","journal-title":"J. Cryst. Growth"},{"key":"10.1016\/j.ijpharm.2008.05.033_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2006.06.001","article-title":"On the misinterpretation of the correlation coefficient in pharmaceutical sciences","volume":"321","author":"Sonnergaard","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0378-5173(03)00153-4","article-title":"In vitro characterization of jet-milled and in-situ-micronized fluticasone-17-propionate","volume":"258","author":"Steckel","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/cg025528p","article-title":"A new molecular modeling approach to predict concomitant nucleation of polymorphs","volume":"2","author":"ter Horst","year":"2002","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/op000058y","article-title":"Crystallisation of polymorphs: thermodynamic insight into the role of solvent","volume":"4","author":"Threlfall","year":"2000","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1023\/A:1011000915769","article-title":"Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids","volume":"18","author":"Tong","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1023\/A:1015358129817","article-title":"Influence of polymorphism on the surface energetics of salmeterol xinafoate crystallized from supercritical fluids","volume":"19","author":"Tong","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib38","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1023\/A:1025758127358","article-title":"Thermal analysis of trace levels of polymorphic impurity in salmeterol xinafoate samples","volume":"20","author":"Tong","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jps.20519","article-title":"Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography","volume":"95","author":"Tong","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0022-3697(99)00260-7","article-title":"Generalization of the Avrami equation for the analysis of non-isothermal transformation kinetics. Application to the crystallization of the Cu0.20As0.30Se0.50 alloy","volume":"61","author":"Vazquez","year":"2000","journal-title":"J. Phys. Chem. Solids"},{"key":"10.1016\/j.ijpharm.2008.05.033_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.physchem.48.1.125","article-title":"Kinetics in solids","volume":"48","author":"Vyazovkin","year":"1997","journal-title":"Annu. Rev. Phys. Chem."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1023\/A:1016232230638","article-title":"Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability","volume":"12","author":"Ward","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0378-5173(98)00247-6","article-title":"Characterisation of the surface energetics of milled dl-propranolol hydrochloride using inverse gas chromatography and molecular modelling","volume":"174","author":"York","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.addr.2003.10.009","article-title":"Phase transformation considerations during process development and manufacture of solid oral dosage forms","volume":"56","author":"Zhang","year":"2004","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.ijpharm.2008.05.033_bib45","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/jps.10425","article-title":"Crystallization kinetics of amorphous nifedipine studied by model-fitting and model-free approaches","volume":"92","author":"Zhou","year":"2003","journal-title":"J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517308004079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517308004079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T20:57:22Z","timestamp":1545944242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517308004079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0378517308004079"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2008.05.033","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}